Cost-utility analysis of von Willebrand disease screening in adolescents with menorrhagia

Journal of Pediatrics

Volumn 157, Issue 3, 2010, Pages

  Sidonio Jr , Robert Francis ^a   Smith, Kenneth J ^b   Ragni, Margaret V ^c  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

ACOG; American College of Obstetricians and Gynecologists; Deep vein thrombosis; DVT; ICER; Incremental cost effectiveness ratio; OCP; Oral contraceptive pill; QALY; Quality adjusted life year; von Willebrand disease; VWD

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADOLESCENT; ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; DYING; FEMALE; HUMAN; MARKOV MODEL; MENORRHAGIA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; SCREENING TEST; VON WILLEBRAND DISEASE; COMPLICATION; COST BENEFIT ANALYSIS; DECISION SUPPORT SYSTEM; ECONOMICS; PROBABILITY; VON WILLEBRAND DISEASES;

ADOLESCENT; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; FEMALE; HUMANS; MARKOV CHAINS; MENORRHAGIA; VON WILLEBRAND DISEASES;

EID: 84923697766     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2010.03.009     Document Type: Article

References (26)

1. A. James, D. Matchar, and E. Myers Testing for von Willebrand disease in women with menorrhagia: a systematic review Obstet Gynecol 104 2004 381 388
2. From The 2007 Diagnosis, Evaluation and Management of von Willebrand disease clinical practice guideline. Journal Available from: http://www.nhbli.nih.gov/guidelines/vwd/index.htm. Accessed July 1, 2009.
3. American Congress of Obstetricians and Gynecologists Von Willebrand's disease in gynecologic practice Obstet Gynecol 98 2001 1185 1186
4. M.V. Ragni, F.A. Bontempo, and A.C. Hassett Von Willebrand disease and bleeding in women Haemophilia 5 1999 313 317
5. P.A. Kouides Menorrhagia from a haemotologist's point of view, I: initial evaluation Haemophilia 8 2002 330 338
6. J.E. Siegel, and P.A. Kouides Menorrhagia from a haemotologist's point of view, II: management Haemophilia 8 2002 339 347
7. R.A. Kadir, D.L. Ecnomides, C.A. Sabin, D. Owens, and C.A. Lee Variations in coagulation factors in women: effects of age, ethnicity, menstrual cycle and combined oral contraceptive Thromb Haemost 82 1999 1456 1461
8. M.C. Weinstein, J.E. Siegel, M.R. Gold, M.S. Kamlet, and L.B. Russell Recommendations of the Panel on Cost-Effectiveness in Health and Medicine JAMA 276 1996 1253 1258
9. A.H. James, P.A. Kouides, R.A. Abdul-Kadir, M. Edlund, A.B. Federici, and S. Halimeh Von Willebrand disease and other bleeding disorders in women: consensus on diagnosis and mangement from an international expert panel Am J Obstet Gynecol 201 2009 12e1-12e8
10. G.C. Allen, D.R. Armfield, F.A. Bontempo, L.A. Kingsley, N.A. Goldstein, and C. Post Adenotonsillectomy in children with von Willebrand disease Arch Otolaryngol Head Neck Surg 125 1999 547 551
11. A.H. James, and M.G. Jamison Bleeding events and other complications during pregnancy and childbirth in women with von Willebrand disease J Thromb Haemost 5 2007 1165 1169
12. J. Drife Oral contraception and the risk of thromboembolism Drug Safety 25 2002 893 902
13. From the U.S Bureau of Labor statistics web site. Available from: www.bls.gov. Accessed July 1, 2009.
14. R.D. Barr, J. Sek, J. Horsman, W. Furlong, S. Mahassen, and M. Pai Health status and health-related quality-of-life associated with von Willebrand disease Am J Hematol 73 2003 108 114
15. S.R. Kahn, H. Shbaklo, D.L. Lamping, C.A. Holcroft, I. Shrier, and M.J. Miron Determinants of health-related quality of life during the 2 years following deep vein thrombosis J Thromb Haemost 6 2008 1105 1112
16. T.O. Tengs, and A. Wallace One thousand health-related quality-of-life estimates Med Care 38 2000 583 637
17. From the Centers of Medicare and Medicaid Services web site. Available from: www.cms.gov. Accessed Feb 10, 2009.
18. M. Laffan, S.A. Brown, P.W. Collins, A.M. Cumming, F.G. Hill, and D. Keeling The diagnosis of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' Organization Haemophilia 10 2004 199 217
19. From The Healthcare Cost and Utilization Project (HCUP) sponsored by The Agency for Healthcare Research Quality (AHRQ) website. Available from: www.hcupnet.ahrq.gov. Accessed July 1, 2009.
20. R.A. Hirth, M. Chernew, E. Miller, M. Fendrick, and W. Weissert Willingness to pay for a quality-adjusted life year: in search of a standard Health Econ 20 2000 332 342
21. R.S. Braithwaite, D.O. Meltzer, D. Leslie, and M.S. Roberts What does the value of modern medicine say about the $50,000 per quality-adjusted life-year? Med Care 46 2008 349 356
22. S. O'Brien Decision analysis in pediatric hematology Pediatr Clin North Am 55 2008 287 304
23. L.R. Goldberg, and M.V. Ragni Bleeding Score as a Preoperative Predictor of Postoperative Bleeding in Type 1 Von Willebrand Disease Blood 2006 303a:4394
24. R.F. Sidonio, P.H. Shaw, and S. Gunawardena Predictors of bleeding disorders in children: a single institution's experience Pediatr Blood Cancer 52:6 2009 711
25. M. Bowan, J. Riddel, M.L. Rand, A. Tosetto, M. Silva, and A.H. James Evaluation of the diagnostic utility for von Willebrand disease of a pediatric bleeding questionnaire J Thromb Haemost 7 2009 1418 1421
26. C.S. Phillip, A. Dilley, C.H. Miller, B. Evatt, A. Barnwal, and R. Schwartz Platelet functional defects in women with unexplained menorrhagia J Thromb Haemost 1 2003 477 484